California state appeals court issues stay, End of Life Option back in effect.

This Weekly’s Hot Topics

  • California state appeals court issues stay, End of Life Option back in effect. (California News)
  • The Trump Administration is seeking stakeholder feedback. (National News)
  • Submit ideas by June 29for CMS’ Promoting Interoperability (CMS News)

The state appeals court has issued a stay, at least for now, putting California’s End of Life Option back into effect. California’s law, allowing terminally ill people to end their lives, was declared unconstitutional last month by a judge because it was voted on during a special session. For more information click here and go to California News.

Rep. Doris Matsui (D-CA) introduced a provider-friendly bill to reform the 340B drug discount program, including explicitly laying out a purpose for the 340B program that says hospitals do not necessarily have to forward drug discounts to patients and reversing the CMS cut to hospitals’ Medicare reimbursement for 340B drugs. For more information click here and go to MOASC News.

The Trump Administration is seeking stakeholder feedback on the American Patients First: The Trump Administration Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs. The document identifies challenges in the American prescription drug market, such as high list prices for drugs, and high and rising out-of-pocket costs for consumers. For more information click here and go to National News.

Last week, CMS released updates to the Merit-based Incentive Payment System (MIPS) eligible clinicians by updating the MIPS Participation Lookup Tool and renaming it the Quality Payment Program (QPP) Participation Lookup Tool and adding predictive Qualifying APM Participant (QP) status. Eligible clinicians in Advanced Alternative Payment Models (APMs) who meet certain criteria are considered QPs and are excluded from MIPS. For more information click here and go to CMS News.

 

To view the complete California Oncology Weekly Newsletter, click on the date below.

June 19. 2018



No comments have been posted yet.